• Sterile drug maker Nexus launches $250M U.S. manufacturing project fiercepharma
    July 13, 2019
    For its first 15 years, Nexus Pharmaceuticals has relied on contractors to manufacture the sterile injectable meds it develops. Figuring it is high time to do that itself, the Chicago-area company has launched a $250 million project that will give it that
PharmaSources Customer Service